Comparative Evaluation of Desensitizing Efficacy of Dentifrice Containing 5% Fluoro Calcium Phosphosilicate versus 5% Calcium Sodium Phosphosilicate: A Randomized Controlled Clinical Trial

S Ashwini, K Swatika, D N Kamala, S Ashwini, K Swatika, D N Kamala

Abstract

Background: A considerable number of agents are effective in the treatment of dentin hypersensitivity (DH). The present 2 months' randomized clinical trial compared the desensitizing efficacy of dentifrice containing 5% fluoro calcium phosphosilicate versus 5% calcium sodium phosphosilicate in participants with sensitive teeth.

Materials and methods: A total of 60 participants above 18 years of age with a history of DH who displayed a visual analog scale (VAS) score of ≥ 4 to both subjective and thermal sensitivity in at least two teeth at the qualifying as well as baseline visit were considered eligible. Participants were randomly allocated to one of the following dentifrices: 5% fluoro calcium phosphosilicate; 5% calcium sodium phosphosilicate; and a standard dentifrice containing fluoride. Sensitivity scores (VAS) were measured at baseline, immediately after scaling and root planning, at 15, 30, and at 60 days.

Results: A statistically significant reduction in symptoms for all treatment groups from baseline to 15, 30, and 60 days for both measures of sensitivity was observed. A significant reduction in DH with time for all the variables during the 8 weeks of the active phase of the study independent of treatment groups was noted. However, the fluoro calcium phosphosilicate group showed a higher degree of effectiveness in reducing DH, followed by calcium sodium phosphosilicate then standard fluoride dentifrices.

Conclusion: Under the conditions of a clinical trial, the fluoro calcium phosphosilicate group showed a comparable reduction in the symptoms of DH.

Keywords: Calcium sodium phosphosilicate; dentifrice; dentinal hypersensitivity; desensitizing toothpaste; fluoro calcium phosphosilicate; randomized clinical trial; visual analog score.

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Consort chart
Graph 1
Graph 1
Comparison of mean Visual Analog Scale scores for subjective sensitivity between different time intervals within each study group
Graph 2
Graph 2
Comparison of mean visual analog scale scores for thermal sensitivity between different time intervals within each study group

References

    1. Holland GR, Narhi MN, Addy M, Gangarosa L, Orchardson R. Guidelines for the design and conduct of clinical trials on dentine hypersensitivity. J Clin Periodontol. 1997;24:808–13.
    1. Boiko OV, Baker SR, Gibson BJ, Locker D, Sufi F, Barlow AP, et al. Construction and validation of the quality of life measure for dentine hypersensitivity (DHEQ) J Clin Periodontol. 2010;37:973–80.
    1. Canadian Advisory Board on Dentin Hypersensitivity, Consensus-based recommendations for the diagnosis and management of dentin hypersensitivity. J Can Dent Assoc. 2003;69:221–6.
    1. Hall C, Mason S, Cooke J. Exploratory randomised controlled clinical study to evaluate the comparative efficacy of two occluding toothpastes – A 5% calcium sodium phosphosilicate toothpaste and an 8% arginine/calcium carbonate toothpaste-for the longer-term relief of dentine hypersensitivity. J Dent. 2017;60:36–43.
    1. Shiau HJ. Dentin hypersensitivity. J Evid Based Dent Pract. 2012;12:220–8.
    1. West NX, Seong J, Davies M. Management of dentine hypersensitivity: Efficacy of professionally and self-administered agents. J Clin Periodontol. 2015;42(Suppl 16):S256–302.
    1. Rees JS, Addy M. A cross-sectional study of buccal cervical sensitivity in UK general dental practice and a summary review of prevalence studies. Int J Dent Hyg. 2004;2:64–9.
    1. Pradeep AR, Sharma A. Comparison of clinical efficacy of a dentifrice containing calcium sodium phosphosilicate to a dentifrice containing potassium nitrate and to a placebo on dentinal hypersensitivity: A randomized clinical trial. J Periodontol. 2010;81:1167–73.
    1. Braennstroem M, Astroem A. A study on the mechanism of pain elicited from the dentin. J Dent Res. 1964;43:619–25.
    1. Kaufman HW, Wolff MS, Winston AE, Triol CW. Clinical evaluation of the effect of a remineralizing toothpaste on dentinal sensitivity. J Clin Dent. 1999;10:50–4.
    1. Lussi A, Ganss C. Monogr Oral Sci. Vol. 25. Basel: Karger; 2014. Erosive Tooth Wear; pp. 108–22.
    1. Markowitz K, Pashley DH. Discovering new treatments for sensitive teeth: The long path from biology to therapy. J Oral Rehabil. 2008;35:300–15.
    1. Gendreau L, Barlow AP, Mason SC. Overview of the clinical evidence for the use of NovaMin in providing relief from the pain of dentin hypersensitivity. J Clin Dent. 2011;22:90–5.
    1. Jones SB, Parkinson CR, Jeffery P, Davies M, Macdonald EL, Seong J, et al. A randomised clinical trial investigating calcium sodium phosphosilicate as a dentine mineralising agent in the oral environment. J Dent. 2015;43:757–64.
    1. Earl JS, Topping N, Elle J, Langford RM, Greenspan DC. Physical and chemical characterization of the surface layers formed on dentin following treatment with a fluoridated toothpaste containing NovaMin. J Clin Dent. 2011;22:68–73.
    1. LaTorre G, Greenspan DC. The role of ionic release from NovaMin (calcium sodium phosphosilicate) in tubule occlusion: An exploratory in vitro study using radio-labeled isotopes. J Clin Dent. 2010;21:72–6.
    1. Jones JR, Brauer DS, Hupa L, Greenspan DC. Bioglass and bioactive glasses and their impact on healthcare. Int J Appl Glass Sci. 2016;7:423–34.
    1. Wewers ME, Lowe NK. A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health. 1990;13:227–36.
    1. Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short. Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF.36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP) Arthritis Care Res (Hoboken) 2011;63(Suppl 11):S240–52.
    1. Brauer DS, Mneimne M, Hill RG. Fluoride-containing bioactive glasses: Fluoride loss during melting and ion release in tris buffer solution. J Non Cryst Solids. 2011;357:3328–33.
    1. Brauer DS, Karpukhina N, O'Donnell MD, Law RV, Hill RG. Fluoride-containing bioactive glasses: Effect of glass design and structure on degradation, pH and apatite formation in simulated body fluid. Acta Biomater. 2010;6:3275–82.
    1. Mneimne M, Hill RG, Bushby AJ, Brauer DS. High phosphate content significantly increases apatite formation of fluoride-containing bioactive glasses. Acta Biomater. 2011;7:1827–34.
    1. Andersson OH, Kangasniemi I. Calcium phosphate formation at the surface of bioactive glass in vitro . J Biomed Mater Res. 1991;25:1019–30.
    1. Parkinson CR, Willson RJ. A comparative in vitro study investigating the occlusion and mineralization properties of commercial toothpastes in a four-day dentin disc model. J Clin Dent. 2011;22:74–81.
    1. West NX, Macdonald EL, Jones SB, Claydon NC, Hughes N, Jeffery P, et al. Randomized in situ clinical study comparing the ability of two new desensitizing toothpaste technologies to occlude patent dentin tubules. J Clin Dent. 2011;22:82–9.
    1. Satyapal T, Mali R, Mali A, Patil V. Comparative evaluation of a dentifrice containing calcium sodium phosphosilicate to a dentifrice containing potassium nitrate for dentinal hypersensitivity: A clinical study. J Indian Soc Periodontol. 2014;18:581–5.
    1. Acharya AB, Surve SM, Thakur SL. A clinical study of the effect of calcium sodium phosphosilicate on dentin hypersensitivity. J Clin Exp Dent. 2013;5:e18–22.
    1. Li C, Huang J, Liang H. Toothpaste containing NovaMin is applied to treat dentine hypersensitivity. Chin J Tissue Eng Res. 2013;38:6846–52.
    1. Ananthakrishna S, Raghu T, Koshy S, Kumar N. Clinical evaluation of the efficacy of bioactive glass and strontium chloride for treatment of dentinal hypersensitivity. J Interdiscip Dent. 2012;2:92–7.
    1. Pradeep AR, Agarwal E, Naik SB, Bajaj P, Kalra N. Comparison of efficacy of three commercially available dentifrices [corrected] on dentinal hypersensitivity: A randomized clinical trial. Aust Dent J. 2012;57:429–34.
    1. Surve SM, Acharya AB, Shetty A, Thakur SL. Efficacy of calcium sodium phosphosilicate in managing dentinal hypersensitivity. Gen Dent. 2012;60:e308–11.
    1. Feil PH, Grauer JS, Gadbury-Amyot CC, Kula K, McCunniff MD. Intentional use of the Hawthorne effect to improve oral hygiene compliance in orthodontic patients. J Dent Educ. 2002;66:1129–35.
    1. West NX, Addy M, Jackson RJ, Ridge DB. Dentine hypersensitivity and the placebo response. A comparison of the effect of strontium acetate, potassium nitrate and fluoride toothpastes. J Clin Periodontol. 1997;24:209–15.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir